Logo
x

Search

Subscribe Now

Arvinas

Arvinas & Pfizer Reports Topline Data from P-III (VERITAC-2) Trial of Vepdegestrant for Breast Cancer

Arvinas & Pfizer Reports Topline Data from P-III (VERITAC-2) Trial of Vepdegestrant for Breast Cancer

  • March 12, 2025
Arvinas Collaborates with Novartis to Develop and Commercialize ARV-766 for Treating Prostate Cancer

Arvinas Collaborates with Novartis to Develop and Commercialize ARV-766 for Treating Prostate Cancer

  • April 11, 2024
Arvinas Reports Results of ARV-471 in P-I/II Study for the Treatment of Breast Cancer

Arvinas Reports Results of ARV-471 in P-I/II Study for the Treatment of Breast Cancer

  • November 23, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.